These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15921866)

  • 1. AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women.
    Wassmann K; Ghiassi A; Wassmann S; Böhm M; Nickenig G
    Maturitas; 2006 Jan; 53(2):176-83. PubMed ID: 15921866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.
    Wassmann S; Hilgers S; Laufs U; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1208-12. PubMed ID: 12117739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C improves endothelial function in healthy estrogen-deficient postmenopausal women.
    McSorley PT; Young IS; Bell PM; Fee JP; McCance DR
    Climacteric; 2003 Sep; 6(3):238-47. PubMed ID: 14567772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
    Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease.
    Perrone-Filardi P; Corrado L; Brevetti G; Silvestro A; Dellegrottaglie S; Cafiero M; Caiazzo G; Petretta A; Maglione A; Monda C; Guerra G; Marzano A; Cesarano P; Gargiulo P; Chiariello M
    J Clin Hypertens (Greenwich); 2009 May; 11(5):260-5. PubMed ID: 19534023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
    Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
    Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan improves impaired endothelial function in the human coronary artery.
    Iino K; Watanabe H; Iino T; Katsuta M; Koyama T; Kosaka T; Terui G; Ito H
    Coron Artery Dis; 2012 Jun; 23(4):278-83. PubMed ID: 22343799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women.
    Higashi Y; Sanada M; Sasaki S; Nakagawa K; Goto C; Matsuura H; Ohama K; Chayama K; Oshima T
    Hypertension; 2001 Feb; 37(2 Pt 2):651-7. PubMed ID: 11230351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
    Phoon S; Howes LG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic AT1-receptor blockade does not alter cerebral oxygen supply/demand ratio during cardiopulmonary bypass in hypertensive patients.
    Kottenberg-Assenmacher E; Massoudy P; Jakob H; Philipp T; Peters J
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):73-80. PubMed ID: 17976222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study.
    Schmieder RE; Klingbeil AU; Fleischmann EH; Veelken R; Delles C
    J Am Soc Nephrol; 2005 Oct; 16(10):3038-45. PubMed ID: 16120821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
    Tran D; Phoon S; Howes L
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):199-203. PubMed ID: 11881123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Lee Y; Shin EK
    Int J Cardiol; 2006 Mar; 108(1):96-100. PubMed ID: 16246439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program.
    Mitchell GF; Arnold JM; Dunlap ME; O'Brien TX; Marchiori G; Warner E; Granger CB; Desai SS; Pfeffer MA
    Eur J Heart Fail; 2006 Mar; 8(2):191-7. PubMed ID: 16188495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.
    Dorenkamp M; Riad A; Stiehl S; Spillmann F; Westermann D; Du J; Pauschinger M; Noutsias M; Adams V; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2005 Sep; 520(1-3):179-87. PubMed ID: 16139267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.